Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 88 publications
Early oxidative protein modifications and gut damage/leakiness contribute to drug-induced acute liver failure.
Journal: Clinical and molecular hepatology
Published: July 08, 2025
Bile acids in liver and gastrointestinal cancer.
Journal: Seminars in cancer biology
Published: April 19, 2025
Hepatic LRP-1 plays an important role in amyloidosis in Alzheimer's disease mice: Potential role in chronic heavy alcohol feeding.
Journal: Neurobiology of disease
Published: April 08, 2024
Mitochondrial P-JNK target, SAB (SH3BP5), in regulation of cell death.
Journal: Frontiers in cell and developmental biology
Published: December 20, 2023
Oral magnesium prevents acetaminophen-induced acute liver injury by modulating microbial metabolism.
Oral magnesium prevents acetaminophen-induced acute liver injury by modulating microbial metabolism.
Journal: Cell host & microbe
Published: July 20, 2023
Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: February 17, 2023
c-Jun-N Terminal Kinase-Mediated Degradation of γ-Glutamylcysteine Ligase Catalytic Subunit Inhibits GSH Recovery After Acetaminophen Treatment: Role in Sustaining JNK Activation and Liver Injury.
Journal: Antioxidants & redox signaling
Published: November 05, 2022
Modulation of hepatic amyloid precursor protein and lipoprotein receptor-related protein 1 by chronic alcohol intake: Potential link between liver steatosis and amyloid-β.
Journal: Frontiers in physiology
Published: April 27, 2022
Introducing Laurie DeLeve, M.D., Ph.D., Our 2022 AASLD President.
Journal: Hepatology (Baltimore, Md.)
Published: November 29, 2021
Endoplasmic reticulum stress in liver diseases.
Journal: Hepatology (Baltimore, Md.)
Published: November 02, 2021
Key Characteristics of Human Hepatotoxicants as a Basis for Identification and Characterization of the Causes of Liver Toxicity.
Journal: Hepatology (Baltimore, Md.)
Published: March 22, 2021
The gut microbial metabolite, 3,4-dihydroxyphenylpropionic acid, alleviates hepatic ischemia/reperfusion injury via mitigation of macrophage pro-inflammatory activity in mice.
Journal: Acta pharmaceutica Sinica. B
Published: February 28, 2021
Last Updated: 09/26/2026